Eli Lilly and Intuitive Surgical are top players in their respective corners of the healthcare market. Both companies are highly innovative and boast attractive long-term growth opportunities.
ISRG sees appendectomy as a long-term robotic growth market, but reimbursement limits near-term adoption as clinical evidence continues to build.
Tap these five stocks, W, DHR, ISRG, BEAT and CSW, with rising P/E ratios to try out an out-of-the-box approach.
Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $432.83, signifying a +1.6% move from its prior day's close.
Intuitive Surgical is a robotic surgery giant and has delivered a track record of growth. The company's revenue has doubled over five years.
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Intuitive Surgical is extending the lifetimes of some of its instruments. Revenue surged 23% year over year in the first quarter.
Intuitive Surgical (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Abbott Laboratories offers a highly diversified revenue stream across medical devices, diagnostics, nutrition, and generic medicines. Intuitive Surgical maintains a dominant position in robotic-assist
Stryker (NYSE:SYK | SYK Price Prediction) and Intuitive Surgical (NASDAQ:ISRG) both closed the books on Q1 2026 with sharply different results.

Robotics Then & Now: 2000 to 2026 by the Numbers

07:11am, Wednesday, 01'st Jul 2026
In 2000, a “robot” mostly meant a caged arm bolted to a car line, repeating one welded seam. Most could not see, none could leave their cells unsupervised, and a full installation ran into six fig
Intuitive Surgical's earnings have climbed progressively over time. The company's flagship robot has a secure position in operating rooms worldwide.
Intuitive Surgical's Quintuple Aim strategy is driving premium pricing as da Vinci 5 adoption grows, with innovation-led revenue growth outpacing procedure growth.
Over the past decade, Intuitive Surgical's stock has risen more than 400%. The stock has fallen by more than 30% from its all-time high.
In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $404.27, denoting a +1.14% move from the preceding trading day.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE